Sheraz Muhammad Ali, Ahmed Sofia, Ur Rehman Ihtesham
Department of Materials Science and Engineering, The Kroto Research Institute, University of Sheffield , North Campus, Broad Lane, Sheffield , UK.
Pharm Dev Technol. 2015 May;20(3):352-60. doi: 10.3109/10837450.2013.871027. Epub 2014 Jan 13.
Tolfenamic acid (TA) has been transformed from crystalline to amorphous state through freeze-drying by using varying ratios of polyacrylic acid (PA) at various pH values. The characterization of the films has been carried out using X-ray diffraction, differential scanning calorimetry, Fourier transform infrared (FTIR) spectrometry and scanning electron microscopy. The results showed a gradual change in the solid state properties of TA and a complete transformation into its amorphous form in 1:8, 1:4, 1:2 and 1:1 ratios at pH 3, 4, 5 and 6, respectively. FTIR spectrometry reveals the formation of a yellow polymorphic form of TA. Polymer molecular weight has also been observed to affect the drug transformation and interaction as the low molecular weight PA (Mw ∼ 1800) was found to be most effective followed by its medium (Mv ∼ 450 000) and high molecular weight (Mv ∼ 3 000 000) forms. No signs of recrystallization in the TA-PA films were noted during the 12-week storage period. PA of low molecular weight has also been found more effective in inhibiting the recrystallization of the melt upon cooling thus proving a valuable polymer in producing stable amorphous solid dispersions of TA.
通过在不同pH值下使用不同比例的聚丙烯酸(PA)进行冷冻干燥,托芬那酸(TA)已从结晶态转变为无定形态。已使用X射线衍射、差示扫描量热法、傅里叶变换红外(FTIR)光谱法和扫描电子显微镜对薄膜进行了表征。结果表明,TA的固态性质逐渐变化,并分别在pH值为3、4、5和6时,以1:8、1:4、1:2和1:1的比例完全转变为其无定形形式。FTIR光谱法揭示了TA黄色多晶型物的形成。还观察到聚合物分子量会影响药物的转变和相互作用,因为发现低分子量PA(Mw ∼ 1800)最有效,其次是其中等分子量(Mv ∼ 450 000)和高分子量(Mv ∼ 3 000 000)形式。在12周的储存期内,未观察到TA-PA薄膜中有重结晶迹象。还发现低分子量PA在冷却时更有效地抑制熔体的重结晶,因此证明其在制备稳定的TA无定形固体分散体方面是一种有价值的聚合物。